Copyright © 2018 Claristock. All Right Reserved
Total Mark
78
Above 70 is preferred
Stock Analysis
| Growth Potential | 86 | |
|---|---|---|
| Profitability | 86 | |
| Financial Strength | 81 | |
| Q4 2019 Result | 49 | |
| Q3 2019 Result | 54 | |
| Result 2019 | 64 |
Growth Estimate
| 20 Estimate | 21 Estimate | |
|---|---|---|
| Revenue Growth (%) | 58.5 | 9 |
| EPS Growth (%) | 33.1 | 21.4 |
| ROE (%) | 25.3 | 31 |
| P/E (times) | ... | ... |
Market Analysis
| Market Sentiment | 63 | |
|---|---|---|
| Relative Valuation | 98 | |
| Being a Value Stock | 68 | |
| Absolute Valuation | 29 |
For more detailed information about Bristol-Myers Squibb Co, please go to Yahoo Finance